Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05444699
PHASE4

Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age

Sponsor: University of Oulu

View on ClinicalTrials.gov

Summary

The aim of the trial is to evaluate whether the use of oral prednisolone directed by point-of-care testing is useful in acute wheezing caused by rhinovirus in children aged 6-24 months.

Official title: Oral Prednisolone for Acute Rhinovirus Induced Wheezing in Children Less Than 2 Years of Age: a Point-of-care Testing Guided Randomized, Double-blind, Placebo-controlled Trial

Key Details

Gender

All

Age Range

6 Months - 24 Months

Study Type

INTERVENTIONAL

Enrollment

210

Start Date

2022-10-11

Completion Date

2027-09

Last Updated

2025-02-13

Healthy Volunteers

No

Interventions

DRUG

Prednisolone Sodium Phosphate

Oral suspension administered 1 mg/kg once a day for three days

DRUG

Sugar syrup

Oral suspension administered the same amount in milliliters as experimental product once a day for three days

Locations (2)

SOITE Lastenpäivystys

Kokkola, Finland

OYS Lastenpäivystys

Oulu, Finland